Fig. 3From: Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors“Swimmers Plot” for Individual Patients Progression Free Survival Divided According to Their Tumors FATSI status. Each bar represents one subject on study. X-axis, number of days progression free; Y-axis individual patients. Individuals’ best tumor response outcomes are indicated by labelsBack to article page